In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...

Please provide your email address to receive an email when new articles are posted on . Arteriovenous access use within 1 year after hemodialysis initiation increased in all racial/ethnic groups.

Novel Cell-Based Therapy Addresses Serious Unmet Medical Need, Aims to Reduce Need for Repeat Surgical Procedures and Improve Patient Outcomes CAMBRIDGE, Mass., Feb. 8, 2011 /PRNewswire/ -- Pervasis ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Researchers found that eGFR decline decelerated significantly in patients with AVF/AVG, from -5.6 to -4.1 mL/min/1.73m2 per year. For patients with advanced chronic kidney disease (CKD), timely ...

"Arteriovenous Fistula Pipeline"The therapeutic pipeline for AV fistula creation and maintenance is rapidly evolving, driven by rising ESRD cases and limitations of current surgical methods. Despite ...

The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...

To undergo kidney dialysis, doctors must first surgically create an access route—an arteriovenous fistula—usually in an arm, ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for AV Fistula Needles 2017 - MedCore" report to their offering. An AV fistula needle enables access ...

PORTAGE, Mich., July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy ...